Patient-Reported Outcomes during Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients' and Clinicians' Experiences

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Patient-Reported Outcomes during Immunotherapy for Metastatic Melanoma : Mixed Methods Study of Patients' and Clinicians' Experiences. / Tolstrup, Lærke K.; Pappot, Helle; Bastholt, Lars; Zwisler, Ann Dorthe; Dieperink, Karin B.

I: Journal of Medical Internet Research, Bind 22, Nr. 4, e14896, 2020.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Tolstrup, LK, Pappot, H, Bastholt, L, Zwisler, AD & Dieperink, KB 2020, 'Patient-Reported Outcomes during Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients' and Clinicians' Experiences', Journal of Medical Internet Research, bind 22, nr. 4, e14896. https://doi.org/10.2196/14896

APA

Tolstrup, L. K., Pappot, H., Bastholt, L., Zwisler, A. D., & Dieperink, K. B. (2020). Patient-Reported Outcomes during Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients' and Clinicians' Experiences. Journal of Medical Internet Research, 22(4), [e14896]. https://doi.org/10.2196/14896

Vancouver

Tolstrup LK, Pappot H, Bastholt L, Zwisler AD, Dieperink KB. Patient-Reported Outcomes during Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients' and Clinicians' Experiences. Journal of Medical Internet Research. 2020;22(4). e14896. https://doi.org/10.2196/14896

Author

Tolstrup, Lærke K. ; Pappot, Helle ; Bastholt, Lars ; Zwisler, Ann Dorthe ; Dieperink, Karin B. / Patient-Reported Outcomes during Immunotherapy for Metastatic Melanoma : Mixed Methods Study of Patients' and Clinicians' Experiences. I: Journal of Medical Internet Research. 2020 ; Bind 22, Nr. 4.

Bibtex

@article{ec4b1b159c284af791819baafd201c37,
title = "Patient-Reported Outcomes during Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients' and Clinicians' Experiences",
abstract = "Background: The benefits of electronic patient reported outcomes (PRO) questionnaires have been demonstrated in many settings, including in hospitals and patient homes. However, it remains to be investigated how melanoma patients and their treating clinicians experience the electronic self-reporting of side effects and the derived communication. Objective: The primary objective of this study was to examine patients' and clinicians' experiences with an eHealth intervention for weekly monitoring of side effects during treatment with immunotherapy. Methods: An eHealth intervention based on questions from the PRO-Common Terminology Criteria for Adverse Events (CTCAE) library was used and tested in a randomized clinical trial with patients receiving immunotherapy for malignant melanoma and clinicians at a university hospital in Denmark. On a weekly basis, patients reported their symptoms from home during the treatment via a provided tablet. The electronic patient reports were available to clinicians in the outpatient clinic. A mixed methods approach was applied to investigate the patients' and clinicians' experiences with the intervention. Data from patient experiences were collected in a short survey, the Patient Feedback Form. Moreover, a subset of the patients participating in the survey was interviewed about their experience. Furthermore, one focus group interview with clinicians was carried out to elucidate their views. Results: A total of 57 patients completed the Patient Feedback Form, and 14 patients were interviewed. The focus group interview included 5 clinicians. Overall, patients and clinicians were satisfied with the tool. They believed it enhanced patients' awareness of side effects and increased their feeling of involvement. The patients reported that it was easy to fill out the questionnaire and that it made sense to do so. However, a minority of the patients expressed in the interviews that they did not believe that the health care professionals had seen their reports when they came to the clinic, and that the reporting did not lead to increased contact with the department. Conclusions: Overall, satisfaction with the eHealth intervention was high among patients and their treating clinicians. The tool was easy to use and contributed to greater symptom awareness and patient involvement. Thus, in terms of patient and clinician satisfaction with the tool, it makes sense to continue using the tool beyond the project period.",
keywords = "Cpis, interviews, Side effects, adverse events, patient-reported outcomes, pro-ctcae, melanoma, ehealth, immunotherapy, patient satisfaction",
author = "Tolstrup, {L{\ae}rke K.} and Helle Pappot and Lars Bastholt and Zwisler, {Ann Dorthe} and Dieperink, {Karin B.}",
year = "2020",
doi = "10.2196/14896",
language = "English",
volume = "22",
journal = "Journal of Medical Internet Research",
issn = "1439-4456",
publisher = "JMIR Publications",
number = "4",

}

RIS

TY - JOUR

T1 - Patient-Reported Outcomes during Immunotherapy for Metastatic Melanoma

T2 - Mixed Methods Study of Patients' and Clinicians' Experiences

AU - Tolstrup, Lærke K.

AU - Pappot, Helle

AU - Bastholt, Lars

AU - Zwisler, Ann Dorthe

AU - Dieperink, Karin B.

PY - 2020

Y1 - 2020

N2 - Background: The benefits of electronic patient reported outcomes (PRO) questionnaires have been demonstrated in many settings, including in hospitals and patient homes. However, it remains to be investigated how melanoma patients and their treating clinicians experience the electronic self-reporting of side effects and the derived communication. Objective: The primary objective of this study was to examine patients' and clinicians' experiences with an eHealth intervention for weekly monitoring of side effects during treatment with immunotherapy. Methods: An eHealth intervention based on questions from the PRO-Common Terminology Criteria for Adverse Events (CTCAE) library was used and tested in a randomized clinical trial with patients receiving immunotherapy for malignant melanoma and clinicians at a university hospital in Denmark. On a weekly basis, patients reported their symptoms from home during the treatment via a provided tablet. The electronic patient reports were available to clinicians in the outpatient clinic. A mixed methods approach was applied to investigate the patients' and clinicians' experiences with the intervention. Data from patient experiences were collected in a short survey, the Patient Feedback Form. Moreover, a subset of the patients participating in the survey was interviewed about their experience. Furthermore, one focus group interview with clinicians was carried out to elucidate their views. Results: A total of 57 patients completed the Patient Feedback Form, and 14 patients were interviewed. The focus group interview included 5 clinicians. Overall, patients and clinicians were satisfied with the tool. They believed it enhanced patients' awareness of side effects and increased their feeling of involvement. The patients reported that it was easy to fill out the questionnaire and that it made sense to do so. However, a minority of the patients expressed in the interviews that they did not believe that the health care professionals had seen their reports when they came to the clinic, and that the reporting did not lead to increased contact with the department. Conclusions: Overall, satisfaction with the eHealth intervention was high among patients and their treating clinicians. The tool was easy to use and contributed to greater symptom awareness and patient involvement. Thus, in terms of patient and clinician satisfaction with the tool, it makes sense to continue using the tool beyond the project period.

AB - Background: The benefits of electronic patient reported outcomes (PRO) questionnaires have been demonstrated in many settings, including in hospitals and patient homes. However, it remains to be investigated how melanoma patients and their treating clinicians experience the electronic self-reporting of side effects and the derived communication. Objective: The primary objective of this study was to examine patients' and clinicians' experiences with an eHealth intervention for weekly monitoring of side effects during treatment with immunotherapy. Methods: An eHealth intervention based on questions from the PRO-Common Terminology Criteria for Adverse Events (CTCAE) library was used and tested in a randomized clinical trial with patients receiving immunotherapy for malignant melanoma and clinicians at a university hospital in Denmark. On a weekly basis, patients reported their symptoms from home during the treatment via a provided tablet. The electronic patient reports were available to clinicians in the outpatient clinic. A mixed methods approach was applied to investigate the patients' and clinicians' experiences with the intervention. Data from patient experiences were collected in a short survey, the Patient Feedback Form. Moreover, a subset of the patients participating in the survey was interviewed about their experience. Furthermore, one focus group interview with clinicians was carried out to elucidate their views. Results: A total of 57 patients completed the Patient Feedback Form, and 14 patients were interviewed. The focus group interview included 5 clinicians. Overall, patients and clinicians were satisfied with the tool. They believed it enhanced patients' awareness of side effects and increased their feeling of involvement. The patients reported that it was easy to fill out the questionnaire and that it made sense to do so. However, a minority of the patients expressed in the interviews that they did not believe that the health care professionals had seen their reports when they came to the clinic, and that the reporting did not lead to increased contact with the department. Conclusions: Overall, satisfaction with the eHealth intervention was high among patients and their treating clinicians. The tool was easy to use and contributed to greater symptom awareness and patient involvement. Thus, in terms of patient and clinician satisfaction with the tool, it makes sense to continue using the tool beyond the project period.

KW - Cpis, interviews

KW - Side effects, adverse events, patient-reported outcomes, pro-ctcae, melanoma, ehealth, immunotherapy, patient satisfaction

U2 - 10.2196/14896

DO - 10.2196/14896

M3 - Journal article

C2 - 32271150

AN - SCOPUS:85083536939

VL - 22

JO - Journal of Medical Internet Research

JF - Journal of Medical Internet Research

SN - 1439-4456

IS - 4

M1 - e14896

ER -

ID: 255842444